Literature DB >> 2543872

New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumor.

Y Nishiwaki1, S Nakamura, S Sakaguchi.   

Abstract

A new sensitizing method of photodynamic therapy for malignant tumors and its effects was studied. Prepared for the study were pheophorbide a (Phd), dissolved in an oily contrast medium, Lipiodol (LPD-Phd), and water-soluble pheophorbide a (W-S Phd) as sensitizers, and VX-2 tumor in rabbit livers. The Phd distribution was compared after intraarterial (i.a.) administration of LPD-Phd or W-S Phd and intravenous (i.v.) administration of W-S Phd. Phd was extracted with methanol at 24 h after injection, and the supernatant absorbance was measured at 670 nm by spectrophotometry. The tumor showed higher values of Phd than did the liver with LPD-Phd i.a. and W-S Phd i.a. (P less than .01). Conversely, the tumor accumulated less Phd than did the liver with W-S Phd i.v. (P less than .05). We subsequently produced severe photo-destruction in a Walker tumor in a Sprague-Dawley rat liver with slight damage to adjacent liver tissue using LPD-Phd i.a. and Nd-YAG dye laser irradiation at 670 nm. The intraarterial administration of a photosensitizer may make it possible to treat liver tumors by photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543872     DOI: 10.1002/lsm.1900090308

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

1.  Fluorescence tomographic imaging in turbid media using early-arriving photons and Laplace transforms.

Authors:  J Wu; L Perelman; R R Dasari; M S Feld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 2.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

3.  Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.

Authors:  K Svanberg; D L Liu; I Wang; S Andersson-Engels; U Stenram; S Svanberg
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.

Authors:  J P Rovers; A E Saarnak; A Molina; J J Schuitmaker; H J Sterenborg; O T Terpstra
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

5.  Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer.

Authors:  M R Hamblin; M Del Governatore; I Rizvi; T Hasan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  Fluorescence characteristics and lifetime images of photosensitizers of talaporfin sodium and sodium pheophorbide a in normal and cancer cells.

Authors:  Kamlesh Awasthi; Kazuhito Yamamoto; Kazunari Furuya; Takakazu Nakabayashi; Liming Li; Nobuhiro Ohta
Journal:  Sensors (Basel)       Date:  2015-05-18       Impact factor: 3.576

Review 7.  Nanocomposites for X-Ray Photodynamic Therapy.

Authors:  Zaira Gadzhimagomedova; Peter Zolotukhin; Oleg Kit; Daria Kirsanova; Alexander Soldatov
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

8.  Interstitial photodynamic therapy in a rat liver metastasis model.

Authors:  R van Hillegersberg; J P Marijnissen; W J Kort; P E Zondervan; O T Terpstra; W M Star
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

9.  Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases.

Authors:  J P Rovers; J J Schuitmaker; A L Vahrmeijer; J H van Dierendonck; O T Terpstra
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

Review 10.  Animal models for photodynamic therapy (PDT).

Authors:  Zenildo Santos Silva; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes; Ying-Ying Huang; Michael R Hamblin
Journal:  Biosci Rep       Date:  2015-09-28       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.